Idogen AB

Idogen is a research company. The company's business focus is on developing vaccines for the treatment of diseases that adversely affect the immune system. The vaccines are intended to be used in the cases where autoimmune diseases have occurred and after organ rejection, particularly in the cases where antibodies have been formed against the ingestion of the regular medication of the patient. The company was founded in 2008 and is based in Lund.

Quotes for Idogen AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Anders Karlsson

Chairperson of the Board

  • Agneta Edberg

Board

  • Christina Herder
  • Leif G Salford
  • Sharon Longhurst
  • Articles of association

    • News

    Show More

    Analysis

    Videos

    BioStock VD-intervju Idogen

    Life Science-dagen 2020 - Idogen

    Idogen Emission

    Idogen summerar året med att viktiga milstolpar uppnåtts

    Largest Owners

    Name Capital % Votes % Date
    Avanza Pension 7,47 7,47 2023-06-28
    Handelsbanken Liv Försäkring AB 2,63 2,63 2023-06-28
    Daniel Bengtsson 2,25 2,25 2023-06-28
    Carsten Lindholm 1,63 1,63 2023-06-28
    Anders Erik Johansson 1,59 1,59 2023-06-28
    Investment Aktiebolaget Balticum 1,48 1,48 2023-06-28
    Roland Bengtsson 1,47 1,47 2023-06-28
    Hans Wihlborg 1,47 1,47 2023-06-28
    Ingvar Karlsson 1,34 1,34 2023-06-28
    Alexander Baecklund 1,11 1,11 2023-06-28

    Annual reports, prospectus etc.